[Skip to content]

tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load
Monday 27 September 2021
Salford GP Header Montage
Latest News:
RSS icon
Search
.
Medicine, tablets, pills

Formulary

This is an electronic version of our Formulary written in conjunction with the Medicine Management Committee and the Pharmacy department.   The purpose of the Formulary is:

  • To promote safe, rational and cost effective prescribing within the Trust.
  • To help select the most appropriate drug amongst the many available.

 

This formulary is intended to act as a rapid reference source.  It is intended for the guidance of medical practitioners, nurses and other healthcare workers.

 

For local GPs and Non-medical prescribers working in the community there is the Greater Manchester Joint Formulary produced by the Greater Manchester Medicines Management Group (GMMMG).  The formulary ensures that patients receive seamless care across the primary-secondary care interface and reduces the need for switching programmes. All medicines recommended for use in the NHS in a NICE Technology Assessment (TA) are approved for use in Greater Manchester, the GMMMG site provides a list of medicines with a positive recommendation from  NICE and provides links to these TAs in the GMMMG formulary.  In the SRFT formulary below all the drugs with a positive NICE TA that are applicable to SRFT are included in the formulary.

 

How to use

All medicines are listed alphabetically using the generic name where possible.  Some brand names are used.

 

  1. Type the drug name in the 'Keywords' box

  2. Click on the 'Search' button

  3. Within the results, click on the 'generic name' of the medicine you are looking for.

  4. Click on the 'Link' - this will take you to further information that talks about that medicine. 

 

 

Drug NameBNF CategoryComment / Usage RestrictionsDetails
Anusol1.7.1 Soothing haemorrhoidal preps  
Anusol-HC1.7.2 Compound preps with corticosteroids  
Apixaban2.8.2 Oral anticoagulantsAs an option for prevention of stroke and systemic embolism in people with atrial fibrillation and one or more risk factors, but without underlying heart valve disease. Use in line with NICE guidance. Approved MMG March 18th 2013. Apixiban can be considered as an option for for treating and for preventing recurrent deep vein thrombosis and pulmonary embolism in adults. Use in line with NICE TA341 June 2015. Rivaroxaban is choice in Trust for thromboembolism post knee/hip replacement - however apixaban would be condsidered via IFR process if felt more appropriate. NICE TA275
Apomorphine4.9.1 Dopaminergic drugs used in parkinsonismNeurology only 
Apraclonidine 0.5% eye drops11.6 Treatment of GlaucomaApproved for use for initiation by eye consultants.   Approved Jan 2014 by MMG  
Apremilast (Otezla)See online BNFPsoriasis (Derm) & Psoriatic arthritis (Rheum) As per NICE TA 419 (Derm) & TA433 (Rheum) Approved April 2017 as per specified indications and supporting NICE TA. Previously on formulary ahead of TA from May 2015.  
AprepitantSee online BNFAs per licensed indications below: • Prevention of acute and delayed nausea and vomiting associated with highly emetogenic cisplatin-based cancer chemotherapy in adults.  • Prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy in adults. Approved November 2015 for initiation by Haematology Consultant’s only.  This is not a first line treatment, but is for failure only.   
Aqueous cream13.2.1 Emollients  
Arachis oil enema1.6.3 Faecal softeners  
ArtissSee online BNFTo be used in parotid surgery to prevent need for surgical drains. Approved November 2015 as per licensed indication, for use in parotid surgery only.   

 

All material in this section is aimed at health professionals, but is information currently held within the public domain.   Members of the public seeking advice on medicine-related matters are encouraged to speak with their GP, pharmacist or nurse, or contact NHS Direct on 0845 46 47.